Some couples are unable to achieve a pregnancy for a variety of causes, including but not limited to: advanced reproductive age (>35 yo), poor egg quality, ovarian dysfunction, surgical removal of the ovaries due to chemotherapy or for genetic reasons. For women who have an intact uterus, the use of donor eggs becomes an option to conceive a child.
The egg donation therapy is commonly called “third party reproduction”. Egg donation has been offered in the United States since 1986. This therapeutic modality is nowadays highly regulated by the Federal Drug Administration (FDA). Egg donors must fulfill stringent criteria, put together by the FDA, in order to be considered to become a donor. As egg donation becomes more widely accepted and available, more women are choosing it as an option for infertility treatment.
The egg donation process involves the selection of a donor patient (usually a women younger than 28 years old) by a recipient couple. The egg donor could be known or anonymous. The egg donor will undergo ovulation induction to produce multiple eggs. These eggs are retrieved form the donor and fertilized with the recipient’s male partner sperm. The resulting embryos will then be transferred to the uterus of the recipient’s female partner. It is important to understand the role of each participant (donor, female recipient, male partner) when exploring the option of egg donation.
Egg donation is a successful treatment option for many patients. Often times, the IVF pregnancy success rates using an egg donor are superior to the traditional IVF pregnancy rates. These outcomes reflect the use of healthy eggs donated by young women, overcoming the cause of infertility in a given recipient.
At RMI, we adhere to the rigorous egg donation recruitment and matching standards set by the American Society for Reproductive Medicine (ASRM) and the Federal Drug Administration (FDA). Our egg donation program is dedicated to managing complex donation decisions and to ensuring the confidentiality of both donors and recipients.